Device typeAlpha-fetoprotein-L3 fraction (AFP-L3) IVD, reagent: A biochemical agent intended to be used with a parent IVD to perform a specific function in an assay used to qualitatively and/or quantitatively detect alpha-fetoprotein-L3 fraction (AFP-L3) in a clinical specimen.
FDA categoryTest, Alpha Fetoprotein L3 Subfraction (Afp-L3%), For Hepatocellular Carcinoma Risk Assessment
Device ID04987481164390
Catalog number999-60601
AvailabilityPrescription
MRI safetyLabeling does not contain MRI Safety Information